Cargando…
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform the management of sclerotic disease. To determine which biomechanical parameter(s) can accurately differentiate patients with sclerotic chronic g...
Autores principales: | Baker, Laura X., Chen, Fuyao, Cronin, Austin, Chen, Heidi, Vain, Arved, Jagasia, Madan, Tkaczyk, Eric R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594905/ https://www.ncbi.nlm.nih.gov/pubmed/34790906 http://dx.doi.org/10.1016/j.xjidi.2021.100037 |
Ejemplares similares
-
Treatment of sclerotic chronic graft-versus-host disease with injections of hyaluronidase
por: Cheng, Tiffany W., et al.
Publicado: (2023) -
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
por: Sánchez-Ortega, Isabel, et al.
Publicado: (2016) -
Isomorphic Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease: Report and Review of Chronic Graft-Versus-Host Disease in a Cutaneous Immunocompromised District
por: Cohen, Philip R.
Publicado: (2013) -
Sclerotic Acid
Publicado: (1878) -
Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials
por: Sengsayadeth, Salyka, et al.
Publicado: (2013)